Polaroid Therapeutics
Switzerland - SchlierenBiotechnology
Focus: Polaroid Therapeutics is a Swiss biotech founded in 2022 specializing in antimicrobial coatings and therapies for infectious diseases. The company is in early-stage development with a lean workforce focused on manufacturing and supply chain scale-up.
Profile data last refreshed 16h ago · AI intelligence enriched 1w ago
Open Jobs
21
Should You Work at Polaroid Therapeutics?
AI assessmentPolaroid is a high-risk, potentially high-reward early-stage play for professionals willing to build infrastructure ahead of clinical proof-of-concept, but lack of public data and trial activity warrant cautious due diligence.
Why Work Here
- Ground-floor opportunity at a newly founded (2022) company with a differentiated antimicrobial coatings platform in an undersupplied infectious disease market
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Polaroid Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.